ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,838Medicare Part D Prescriptions Filled, Including Refills
$477K Total Retail Price of All Prescriptions
284 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
POTASSIUM CHLORIDE 332 299
METOPROLOL TARTRATE 319 285
LEVOTHYROXINE SODIUM 276 230
FUROSEMIDE 239 225
LISINOPRIL 214 188
WARFARIN SODIUM 211 208
DONEPEZIL HCL 202 202
OMEPRAZOLE 198 183
SERTRALINE HCL 168 163
HYDROCODONE-ACETAMINOPHEN 155 154 S3
METOPROLOL SUCCINATE 154 142
NAMENDA 148 137
HYDROCHLOROTHIAZIDE 145 135
LANTUS 131 108
SIMVASTATIN 126 112
METFORMIN HCL 98 65
AMLODIPINE BESYLATE 98 92
GABAPENTIN 96 79
DIOVAN 93 93
TERAZOSIN HCL 90 79
POLYETHYLENE GLYCOL 3350 85 66
RANITIDINE HCL 81 69
LOVASTATIN 77 69
LOSARTAN POTASSIUM 76 71
TRAMADOL HCL 76 57
ATORVASTATIN CALCIUM 74 70
CITALOPRAM HBR 74 73
NEXIUM 73 45
CYMBALTA 71 66
QUETIAPINE FUMARATE 68 65
ALLOPURINOL 63 52
CARVEDILOL 61 61
MIRTAZAPINE 61 60
GLIPIZIDE 58 58
ISOSORBIDE MONONITRATE ER 55 50
OXYCODONE-ACETAMINOPHEN 55 47 S2
LYRICA 52 40
CLOPIDOGREL 51 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 4, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.